Skip to main content
. 2009 May;11(3):182–185. doi: 10.2353/jmoldx.2009.080098

Figure 2.

Figure 2

The efficacy of using plasma DNA levels to distinguish lung cancer patients from healthy controls was tested using a receiver operating characteristic curve.